China NMPA Drug Inspection - Pharmaceutical manufacturing and distribution enterprises in the jurisdiction - Antibiotics, imported drugs, etc. (a total of 77 batches were sampled)

The Eighth Inspection Division of the Heilongjiang Provincial Drug Administration recently conducted a series of drug sampling and inspection activities aimed at enhancing safety standards and professional law enforcement. A key event occurred on July 14th, involving a joint symposium and inspection with Nenjiang County Tianrun Baixing Pharmaceutical Chain Co., Ltd. These activities were carried out under the regulatory framework of the Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and the Administrative Measures for Drug Quality Sampling and Inspection. During the process, inspectors sampled 77 batches of drugs across 13 specialized areas, including antibiotics and imported products. The oversight revealed 50 potential safety risks among enterprises within the jurisdiction. To address these issues, the division provided on-site guidance and answered technical queries from business operators. As a result, 36 of the identified risks have already been rectified. Required actions moving forward include the systematic resolution of the remaining hidden dangers and the high-quality completion of scheduled drug sampling tasks to ensure comprehensive public health protection.